A model of GDNF Gene therapy in mice with 6-hydroxydopamine lesions: Time course of neurorestorative effects and ERK1/2 activation

Journal of Parkinson's Disease

Volumn 2, Issue 4, 2012, Pages 333-348

  Lindgren, Niklas ^a   Francardo, Veronica ^a   Quintino, Luis ^a   Lundberg, Cecilia ^a   Cenci, M Angela ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

GDNF; MAPK; mitogen activated protein kinases; neuroprotection; Neurotoxin; rodent; trophic factor

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LENTIVIRUS VECTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENETIC ENGINEERING; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BEHAVIOR, ANIMAL; GENETIC THERAPY; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MAP KINASE SIGNALING SYSTEM; MICE; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; TIME FACTORS; TREATMENT OUTCOME; TYROSINE 3-MONOOXYGENASE;

EID: 84874820297     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-012146     Document Type: Article

References (51)

1. Hou JG, Lin L-FH, & Mytilineou C (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and protomotes their survival and regrowth after damage by 1-methyl-4- phenylpyridinium. J Neurochem, 66, 74-82. (Pubitemid 26010766)
2. Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, & Bohn MC (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science, 275, 838-841. (Pubitemid 27074886)
3. Kearns CM, & Gash DM (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res, 672, 104-111.
4. Bensadoun JC, Deglon N, Tseng JL, Ridet JL, Zurn AD, & Aebischer P (2000) Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp Neurol, 164, 15-24. (Pubitemid 30490718)
5. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, & Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature, 380, 252-255. (Pubitemid 26090648)
6. Georgievska B, Kirik D, Rosenblad C, Lundberg C, & Björklund A (2002) Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using lentiviral vector. Neuroreport, 13, 75-82. (Pubitemid 34102030)
7. Love S, Plaha P, Patel NK, Hotton GR, Brooks DJ, & Gill SS (2005) Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med, 11, 703-704. (Pubitemid 41021193)
8. Salvatore MF, Zhang J-L, Large DM, Wilson PE, Gash CR, Thomas TC, Haycock JW, Bing G, Stanford JA, Gash DM, & Gerhardt GA (2004) Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. J Neurochem, 90, 245-254. (Pubitemid 38879178)
9. Kobori N, Waymire JC, Haycock JW, Clifton GL, & Dash PK (2004) Enhancement of tyrosine hydroxylase phospho-rylation and activity by glial cell line-derived neurotrophic factor. J Biol Chem, 279, 2182-2191. (Pubitemid 38084492)
10. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis J-C, Hu S, Altrock BW, & Fox GM (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell, 85, 1113-1124. (Pubitemid 26231176)
11. Cacalano G, Farinas I, Wang L-C, Hagler K, Forgie A, Moore M, Armanini M, Philips H, Ryan AM, Reichardt l F, Hynes M, Davies A, & Rosenthal A (1998) GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron, 21, 53-62. (Pubitemid 28355691)
12. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, & Rosenthal A (1996) Characterization of a multicomponent receptor for GDNF. Nature, 382, 80-83. (Pubitemid 26243362)
13. Tansey MG, Baloh RH, Mildbrant J, & Johnson EM (2000) GFRalpha-mediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuon, 25, 611-623.
14. Trupp M, Scott R, Whittemore SR, & Ibanez CF (1999) Ret-dependent and-independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem, 274, 20885-20894.
15. van Weering DH, & Bos JH (1997) Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation. J Biol Chem, 272, 249-254. (Pubitemid 27021152)
16. Worby CA, Vega QC, Zhao Y, Chao HH-J, Seasholtz AF, & Dixon JE (1996) Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J Biol Chem, 271, 23619-23622. (Pubitemid 26327319)
17. Ugarte SD, Lin E, Klann E, Zigmond MJ, & Perez RG (2003) Effects of GDNF on 6-OHDA-induced death in a dopamin-ergic cell line: Modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res, 73, 105-112. (Pubitemid 36791375)
18. Rangasamy SB, Soderstrom K, Bakay RA, & Kordower JH (2010) Neurotrophic factor therapy for Parkinson's disease. Prog Brain Res, 184, 237-264.
19. Nielsen J, Gotfryd K, Li S, Kulahin N, Soroka V, Rasmussen KK, Bock E, & Berezin V (2009) Roleofglialcell line-derived neurotrophic factor (GDNF)-neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF. J Neurosci, 29, 11360-11376.
20. Jakobsson J, Ericson C, Jansson M, Bjork E, & Lundberg C (2003) Targeted transgene expression in rat brain using lentiviral vectors. J Neurosci Res, 73, 876-885. (Pubitemid 37071743)
21. Georgievska B, Kirik D, & Björklund A (2004) Overex-pression of glial cell line-revide neurotrophic factor using a lentiviral vector induces time-and dose-dependent down-regulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J Neurosci, 24, 6437-6445. (Pubitemid 38971690)
22. Georgievska B, Kirik D, & Bjorklund A (2002) Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp Neurol, 177, 461-474. (Pubitemid 35366135)
23. Naldini L, Blomer U, Gage FH, Trono D, & Verma IM (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A, 93, 11382-11388. (Pubitemid 26347130)
24. Lundblad M, Picconi B, Lindgren H, & Censi MA (2004) A modelof L-DOPA-induceddyskinesia in 6-hydroxydopamine lesioned mice: Relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis, 16, 110-123. (Pubitemid 38569802)
25. Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, & Cenci MA (2011) Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease. Neurobiol Dis, 42, 327-340.
26. Paxinos G, & Franklin KBJ (2001) The Mouse Brain inStereo-taxic Coordinates. Academic Press, San Diego.
27. West MJ (1999) Stereological methods for estimating the total number of neurons and synapses: Issues of precision and bias. Trends Neurosci, 22, 51-61. (Pubitemid 29125550)
28. West MJ, Ostergaard K, Andreassen OA, & Finsen B (1996) Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method. J Comp Neurol, 370, 11-22. (Pubitemid 26192341)
29. Lindgren N, Leak RK, Carlson KM, Smith AD, & Zigmond MJ (2008) Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease. J Neurosci Res, 86, 2039-2049.
30. Håkansson K, Pozzi L, Usiello A, Haycock JW, Borelli F, & Fisone G (2004) Regulation of striatal tyrosine hydroxy-lase phosphorylation by acute and chronic haloperidol. Eur J Neurosci, 20, 1108-1112. (Pubitemid 39141317)
31. Lindgren N, Goiny M, Herrera-Marschitz M, Haycock JW, Hökfelt T, & Fisone G (2002) Activation of extracellular signal-regulated kinases 1 and 2 by depolarization stimulates tyrosine hydroxylase phosphorylation and dopamine synthesis in rat brain. Eur J Neurosci, 15, 769-773. (Pubitemid 35471943)
32. Alvarez-Fischer D, Henze C, Strenzke C, Westrich J, Ferger B, Hoglinger GU, Oertel WH, & Hartmann A (2008) Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice. Exp Neurol, 210, 182-193. (Pubitemid 351265366)
33. Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leven-thal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, & Aebischer P (2000) Neurode-generation prevented by lentiviral vector delivery of GDNF in primate modelsofParkinson's disease.Science, 290, 767-773.
34. Rosenblad C, Georgievska B, & Kirik D (2003) Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur J Neurosci, 17, 260-270. (Pubitemid 36459505)
35. Rosenblad C, Kirik D, & Björklund A (2000) Sequential administrationofGDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp Neurol, 161, 503-516. (Pubitemid 30137010)
36. Bezard E, Dovero S, Imbert C, Boraud T, & Gross CE (2000) Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice. Synapse, 38, 363-368.
37. Drinkut A, Tereshchenko Y, Schulz JB, Bahr M, & Kugler S (2012) Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery. Mol Ther, 20, 534-543.
38. Safi R, Gardaneh M, Panahi Y, Maghsoudi N, Zaefizadeh M, & Gharib E (2012) Optimized quantities of GDNF overex-pressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity. J Mol Neu-rosci, 46, 654-665.
39. Ericson C, Georgievska B, & Lundberg C (2005) Ex vivogene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease. Eur J Neurosci, 22, 2755-2764. (Pubitemid 41811272)
40. Kirik D, Rosenblad C, Björklund A, & Mandel RJ (2000) Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intanigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci, 20, 4686-4700. (Pubitemid 30396634)
41. Salvatore MF, Gerhardt GA, Dayton RD, Klein RL, & Stanford JA (2009) Bilateral effects of unilateral GDNF administration on dopamine-and GABA-regulating proteins in the rat nigrostriatal system. Exp Neurol, 219, 197-207.
42. Chen Z, Chai Y, Cao L, Huang A, Cui R, Lu C, & He C (2001) Glial cell line-derived neurotrophic factor promotes survival and induces differentiation through the phosphatidylinosi-tol 3-kinase and mitogen-activated protein kinase pathway respectively in PC12 cells. Neuroscience, 104, 593-598. (Pubitemid 32493747)
43. Ho TW, Bristol LA, Coccia C, Li Y, Milbrandt J, Johnson E, Jin L, Bar-Peled O, Griffin JW, & Rothstein JD (2000) TGFbeta trophic factors differentially modulate motor axon outgrowth and protection from excitotoxicity. Exp Neurol, 161, 664-675. (Pubitemid 30137023)
44. Trupp M, Scott R, Whittemore SR, & Ibanez CF (1999) Ret-dependent and-independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem, 274, 20885-20894.
45. Stultz CM, Levin AD, & Edelman ER (2002) Phosphorylation-induced conformational changes in a mitogen-activated protein kinase substrate. Implications for tyrosine hydroxylase activation. J Biol Chem, 277, 47653-47661. (Pubitemid 36159287)
46. Sutherland C, Alterio J, Campbell DG, Le Bourdelles B, Mallet J, Haavik J, & Cohen P (1993) Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur J Biochem, 217, 715-722. (Pubitemid 23311985)
47. Le Bourdelles B, Horellou P, Le Caer JP, Denefle P, Latta M, Haavik J, Guibert B, Mayaux JF, & Mallet J (1991) Phospho-rylation of human recombinant tyrosine hydroxylase isoforms 1 and 2: An additional phosphorylated residue in isoform 2, generated through alternative splicing. J Biol Chem, 266, 17124-17130. (Pubitemid 21907914)
48. Hebert MA, Van Horne CG, Hoffer BJ, & Gerhardt GA (1996) Functional effects of GDNF in normal rat striatum: Presynap-tic studies using in vivo electrochemistry and microdialysis. J Pharmacol Exp Ther, 279, 1181-1190. (Pubitemid 27166763)
49. Hudson J, Granholm AC, Gerhardt GA, Henry MA, Hoffman A, Biddle P, Leela NS, Mackerlova L, Lile JD, Collins F, & Hoffer BJ (1995) Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull, 36, 425-432.
50. Kobayashi S, Ogren SO, Hoffer BJ, & Olson L (1998) Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neu-rotrophic factor administered into the striatum. Exp Neurol, 154, 302-314. (Pubitemid 29044203)
51. Stanford JA, Salvatore MF, Joyce BM, Zhang H, Gash DM, & Gerhardt GA (2007) Bilateral effects of unilateral intrastri-atal GDNF on locomotor-excited and nonlocomotor-related striatal neurons in aged F344 rats. Neurobiol Aging, 28, 156-165. (Pubitemid 44791630)